GENE ONLINE|News &
Opinion
Blog

2025-11-26|

Study Finds Smaller Microplastics and Nanoplastics Pose Greater Risk to Respiratory Health Due to Deeper Penetration

by GOAI
Share To

Recent research has examined the varying toxicity of microplastics and nanoplastics, focusing on their impact on human health, particularly the respiratory system. The study, conducted by Gosselink, Leonhardt, Höppener, and their team, analyzed how particle size and polymer type influence the potential harm caused by these materials. Researchers aimed to better understand the risks associated with exposure to amorphous micro- and nanoplastics as they become increasingly prevalent in the environment.

The findings highlight that both size and polymer composition play significant roles in determining toxicity levels. Smaller particles were found to pose a greater risk due to their ability to penetrate deeper into biological systems. Additionally, variations in polymer types affected how these particles interact with cells and tissues within the respiratory system. The study provides detailed insights into how these factors contribute to potential health risks associated with microplastic and nanoplastic exposure.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top